ロード中...
The transcription inhibitor lipiarmycin blocks DNA fitting into the RNA polymerase catalytic site
Worldwide spreading of drug-resistant pathogens makes mechanistic understanding of antibiotic action an urgent task. The macrocyclic antibiotic lipiarmycin (Lpm), which is under development for clinical use, inhibits bacterial RNA polymerase (RNAP) by an unknown mechanism. Using genetic and biochemi...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2010
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2928680/ https://ncbi.nlm.nih.gov/pubmed/20562828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emboj.2010.135 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|